216 related articles for article (PubMed ID: 31523926)
1. Design, Synthesis, Molecular Docking, and Cholinesterase Inhibitory Potential of Phthalimide-Dithiocarbamate Hybrids as New Agents for Treatment of Alzheimer's Disease.
Asadi M; Ebrahimi M; Mohammadi-Khanaposhtani M; Azizian H; Sepehri S; Nadri H; Biglar M; Amanlou M; Larijani B; Mirzazadeh R; Edraki N; Mahdavi M
Chem Biodivers; 2019 Nov; 16(11):e1900370. PubMed ID: 31523926
[TBL] [Abstract][Full Text] [Related]
2. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1.
Ali MY; Seong SH; Jung HA; Jannat S; Choi JS
Arch Pharm Res; 2018 Jul; 41(7):753-764. PubMed ID: 30047040
[TBL] [Abstract][Full Text] [Related]
3. Novel chromanone-dithiocarbamate hybrids as multifunctional AChE inhibitors with β-amyloid anti-aggregation properties for the treatment of Alzheimer's disease.
Jiang N; Ding J; Liu J; Sun X; Zhang Z; Mo Z; Li X; Yin H; Tang W; Xie SS
Bioorg Chem; 2019 Aug; 89():103027. PubMed ID: 31176237
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
[TBL] [Abstract][Full Text] [Related]
5. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin-3-carboxamide-N-morpholine Hybrids as New Anti-Alzheimer Agents.
Tehrani MB; Rezaei Z; Asadi M; Behnammanesh H; Nadri H; Afsharirad F; Moradi A; Larijani B; Mohammadi-Khanaposhtani M; Mahdavi M
Chem Biodivers; 2019 Jul; 16(7):e1900144. PubMed ID: 31155827
[TBL] [Abstract][Full Text] [Related]
8. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S
Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation.
Panek D; Więckowska A; Wichur T; Bajda M; Godyń J; Jończyk J; Mika K; Janockova J; Soukup O; Knez D; Korabecny J; Gobec S; Malawska B
Eur J Med Chem; 2017 Jan; 125():676-695. PubMed ID: 27721153
[TBL] [Abstract][Full Text] [Related]
10. Phthalimide-Derived N-Benzylpyridinium Halides Targeting Cholinesterases: Synthesis and Bioactivity of New Potential Anti-Alzheimer's Disease Agents.
Saeedi M; Golipoor M; Mahdavi M; Moradi A; Nadri H; Emami S; Foroumadi A; Shafiee A
Arch Pharm (Weinheim); 2016 Apr; 349(4):293-301. PubMed ID: 26898241
[TBL] [Abstract][Full Text] [Related]
11. Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with neuroprotective and β-secretase inhibition activities.
Ghobadian R; Mahdavi M; Nadri H; Moradi A; Edraki N; Akbarzadeh T; Sharifzadeh M; Bukhari SNA; Amini M
Eur J Med Chem; 2018 Jul; 155():49-60. PubMed ID: 29857276
[TBL] [Abstract][Full Text] [Related]
12. Investigation of multi-target-directed ligands (MTDLs) with butyrylcholinesterase (BuChE) and indoleamine 2,3-dioxygenase 1 (IDO1) inhibition: The design, synthesis of miconazole analogues targeting Alzheimer's disease.
Lu X; He SY; Li Q; Yang H; Jiang X; Lin H; Chen Y; Qu W; Feng F; Bian Y; Zhou Y; Sun H
Bioorg Med Chem; 2018 May; 26(8):1665-1674. PubMed ID: 29475581
[TBL] [Abstract][Full Text] [Related]
13. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.
Jameel E; Meena P; Maqbool M; Kumar J; Ahmed W; Mumtazuddin S; Tiwari M; Hoda N; Jayaram B
Eur J Med Chem; 2017 Aug; 136():36-51. PubMed ID: 28478343
[TBL] [Abstract][Full Text] [Related]
14. Multipotent AChE and BACE-1 inhibitors for the treatment of Alzheimer's disease: Design, synthesis and bio-analysis of 7-amino-1,4-dihydro-2H-isoquilin-3-one derivates.
Zhao XJ; Gong DM; Jiang YR; Guo D; Zhu Y; Deng YC
Eur J Med Chem; 2017 Sep; 138():738-747. PubMed ID: 28728106
[TBL] [Abstract][Full Text] [Related]
15. Search for new multi-target compounds against Alzheimer's disease among histamine H
Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B
Eur J Med Chem; 2020 Jan; 185():111785. PubMed ID: 31669851
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
[TBL] [Abstract][Full Text] [Related]
17. Kinetics and molecular docking studies of loganin, morroniside and 7-O-galloyl-D-sedoheptulose derived from Corni fructus as cholinesterase and β-secretase 1 inhibitors.
Bhakta HK; Park CH; Yokozawa T; Min BS; Jung HA; Choi JS
Arch Pharm Res; 2016 Jun; 39(6):794-805. PubMed ID: 27106028
[TBL] [Abstract][Full Text] [Related]
18. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
Ali MY; Jannat S; Edraki N; Das S; Chang WK; Kim HC; Park SK; Chang MS
Chem Biol Interact; 2019 Aug; 309():108707. PubMed ID: 31194956
[TBL] [Abstract][Full Text] [Related]
19. Identification of aplysinopsin as a blood-brain barrier permeable scaffold for anti-cholinesterase and anti-BACE-1 activity.
Nuthakki VK; Yadav Bheemanaboina RR; Bharate SB
Bioorg Chem; 2021 Feb; 107():104568. PubMed ID: 33418314
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]